[Clinical reliability of a new IgE detection system using chemiluminescent enzyme immunoassay named LUMIWARD immunoassay system].
The measurement of allergen-specific IgE antibodies and total IgE was performed with LUMIWARD immunoassay system (chemiluminescent enzyme immunoassay) using 406 serum samples obtained from patients with various allergic diseases and 81 serum samples from normal donors. These were collected by departments of internal medicine, pediatrics, dermatology and otorynolaryngology at eleven institutes in Japan. In addition to a comparative study with CAP RAST, skin tests were also performed to establish a clinical diagnosis. Simultaneous measurements were performed and an excellent correlation with CAP RAST was observed with a concordance rate of 92.6% and correlation coefficient of 0.922. The specificity determined by the normal serum samples was 96.4% for CAP RAST and 96.2% for LUMIWARD. The sensitivity determined by the samples, of which etiological allergens were identified clinically, was 84.8% for CAP RAST and 85.5% for LUMIWARD. Among them, the sensitivity of skin test was 91.8%. The concordance rate with clinical diagnosis was as high as 90.6% and 90.8% for CAP RAST and LUMIWARD. The normal upper limit of total IgE by cumulative 95% value was calculated to be 170 IU/ml for adult subjects. These results indicate the clinical usefulness of the LUMIWARD immunoassay system in evaluating IgE antibodies and total IgE.
Nakagawa
T
T
Department of Internal Medicine, St. Marianna University.
Miyamoto
T
T
Akiyama
K
K
Makino
S
S
Toda
M
M
Ito
K
K
Suko
M
M
Iikura
Y
Y
Sakaguchi
N
N
Ebisawa
M
M
Baba
M
M
Iwasaki
E
E
Mayumi
M
M
Sasaki
S
S
Yoshida
H
H
Matsunaga
Y
Y
Yamamoto
S
S
Furutani
K
K
Okuda
M
M
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D005069:Evaluation Studies as Topic; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007073:Immunoglobulin E / Q000032:analysis*; D008163:Luminescent Measurements; D012680:Sensitivity and Specificity
D000906:Antibodies; D007073:Immunoglobulin E